Solid Biosciences Completes IPO – Barron’s
Barron’s |
Solid Biosciences Completes IPO
Barron’s The safety of Solid's gene therapy also is an issue following the recent resignation by Dr. James Wilson, one of the leading scientists in the field, from Solid's scientific advisory board due to apparent concerns about the safety of Solid's gene … |
